IQOS Authorized by FDA as Modified Risk Tobacco Product

The U.S. Food and Drug Administration (FDA) has given Altria Group the ok to market its heat not burn device, IQOS, as a modified risk product. This will allow Altria to use a reduced exposure claim when marketing IQOS in the U.S. IQOS is the first next-generation inhalable tobacco product to be authorized as a modified risk tobacco product.

“We’re delighted that the FDA authorized IQOS…

Continue Reading On: Tobacco Business Magazine